March 5, 2019
BURLINGTON, Ontario – March 5, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT...
March 4, 2019
Burlington, Ontario — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce the completion of a vertical amalgamation (the “Amalgamation”) with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation...
February 26, 2019
BURLINGTON, Ontario – February 26, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug delivery solutions, is pleased to provide a business update. RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral...
February 14, 2019
BURLINGTON, Ontario – February 14, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) is pleased to announce that it has appointed Spinnaker Capital Markets Inc. (“Spinnaker”) as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies...
January 23, 2019
BURLINGTON, Ontario – January 23, 2019 – Rapid Dose Therapeutics (“RDT”) (CSE: DOSE) is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT. Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the...
January 15, 2019
BURLINGTON, Ontario – January 15, 2019 – Rapid Dose Therapeutics Inc. (“RDT”) (CSE: DOSE) is pleased to announce its entered into a definitive agreement (the “Agreement”) on January 10, 2019, with Flower One Holdings Inc. (“Flower One”) (CSE: FONE) (OTCQB: FLOOF) pursuant to which Flower...
December 18, 2018
Burlington and Leamington Ontario – December 18, 2018 – Rapid Dose Therapeutics Inc. (“RDT” or the “Company”) (CSE: DOSE) and Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”), executed on...
December 17, 2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.. Burlington Ontario – December 17, 2018. Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that, following completion of the business combination...
December 10, 2018
Toronto, Burlington Ontario – Further to its press release of December 7, 2018, Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (“ACME” or the “Corporation”), is pleased to announce the change of its name from ACME Resources Corp. to Rapid Dose Therapeutics Corp. in connection...
December 7, 2018
Toronto, Burlington Ontario – ACME Resources Corp. (“ACME” or the “Corporation“) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to jointly announce the completion of the three-cornered amalgamation pursuant to an Amended and Restated Amalgamation Agreement (the “Amalgamation Agreement“) as of July 11, 2018 as...